Inhibition of tumor–microenvironment interaction and tumor invasion by small-molecule allosteric inhibitor of DDR2 extracellular domain

Whitney R. Grither, Gregory D. Longmore

Research output: Contribution to journalArticle

23 Scopus citations

Abstract

The action of the collagen binding receptor tyrosine kinase (RTK) discoidin domain receptor 2 (DDR2) in both tumor and tumor stromal cells has been established as critical for breast cancer metastasis. Small molecule inhibitors that target the extracellular domain of RTKs are rare, as they have classically been regarded as too small to block binding with large polypeptide ligands. Here, we report the identification and characterization of a selective, extracellularly acting small molecule inhibitor (WRG-28) of DDR2 that uniquely inhibits receptor–ligand interactions via allosteric modulation of the receptor. By targeting DDR2, WRG-28 inhibits tumor invasion and migration, as well as tumor-supporting roles of the stroma, and inhibits metastatic breast tumor cell colonization in the lungs. These findings represent an approach to inhibiting tumor–stromal interactions and support the development of allosteric inhibitors of DDR2, such as WRG-28, as a promising approach to antimetastasis treatment.

Original languageEnglish
Pages (from-to)E7786-E7794
JournalProceedings of the National Academy of Sciences of the United States of America
Volume115
Issue number33
DOIs
StatePublished - Aug 14 2018
Externally publishedYes

Keywords

  • Allosteric inhibition
  • DDR2
  • Metastasis

Fingerprint Dive into the research topics of 'Inhibition of tumor–microenvironment interaction and tumor invasion by small-molecule allosteric inhibitor of DDR2 extracellular domain'. Together they form a unique fingerprint.

  • Cite this